The UK regulatory agency has been allocated an additional £1 million to support its AI Airlock program, which serves as a controlled environment for testing innovative technologies and addressing specific challenges safely. James Pound, the interim executive director of innovation and compliance at the Medicines and Healthcare products Regulatory Agency (MHRA), emphasized the program’s role in facilitating the investigation of new technologies in a supervised setting. This funding will enable further development and exploration of cutting-edge advancements while ensuring regulatory oversight and safety for potential applications in healthcare and related fields. The initiative aims to foster innovation while maintaining rigorous standards for public health and safety.
Source link
MHRA Launches Second AI Airlock Program for Applications
Leave a Comment
Leave a Comment
